{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:35:08Z","timestamp":1794868508441,"version":"4.9.1"},"reference-count":38,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["SFB54"],"award-info":[{"award-number":["SFB54"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Nicorandil, a balanced vasodilator, is used in the second-line therapy of angina pectoris. In this study, we aimed to illuminate the effects of nicorandil on inflammation, apoptosis, and atherosclerotic plaque progression. Twenty-five LDL-R -\/- mice were fed a high-fat diet for 14 weeks. After 6 weeks mice were randomly allocated to treatment with nicorandil (10 mg\/kg\/day) or tap water. Nicorandil treatment led to a more stable plaque phenotype, displaying an increased thickness of the fibrous cap (p = 0.014), a significant reduction in cholesterol clefts (p = 0.045), and enhanced smooth muscle cell content (p = 0.009). In endothelial cells nicorandil did not reduce the induction of adhesion molecules or proinflammatory cytokines. In H2O2 challenged endothelial cells, pretreatment with nicorandil significantly reduced the percentage of late apoptotic\/necrotic cells (p = 0.016) and the ratio of apoptotic to living cells (p = 0.036). Atherosclerotic lesions of animals treated with nicorandil exhibited a significantly decreased content of cleaved caspase-3 (p = 0.034), lower numbers of apoptotic nuclei (p = 0.040), and reduced 8-oxogunanine staining (p = 0.039), demonstrating a stabilizing effect of nicorandil in established atherosclerotic lesions. We suggest that nicorandil has a positive effect on atherosclerotic plaque stabilization by reducing apoptosis.<\/jats:p>","DOI":"10.3390\/biomedicines9020120","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T06:10:54Z","timestamp":1611727854000},"page":"120","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3539-994X","authenticated-orcid":false,"given":"Max","family":"Lenz","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II\u2014Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Ludwig Boltzmann Institute for Cardiovascular Research, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kaun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II\u2014Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-2837","authenticated-orcid":false,"given":"Konstantin A.","family":"Krychtiuk","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II\u2014Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Ludwig Boltzmann Institute for Cardiovascular Research, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Haider","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II\u2014Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Brekalo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II\u2014Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Maier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II\u2014Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1037-3137","authenticated-orcid":false,"given":"Laura","family":"Goederle","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph J.","family":"Binder","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-5524","authenticated-orcid":false,"given":"Kurt","family":"Huber","sequence":"additional","affiliation":[{"name":"3rd Medical Department for Cardiology and Emergency Medicine, Wilhelminenhospital and Sigmund Freud University, 1160 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8284-2994","authenticated-orcid":false,"given":"Christian","family":"Hengstenberg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II\u2014Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Wojta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II\u2014Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Ludwig Boltzmann Institute for Cardiovascular Research, 1090 Vienna, Austria"},{"name":"Core Facility Imaging, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4819-3190","authenticated-orcid":false,"given":"Philipp J.","family":"Hohensinner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II\u2014Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria"},{"name":"Ludwig Boltzmann Institute for Cardiovascular Research, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7267-3138","authenticated-orcid":false,"given":"Walter S.","family":"Speidl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II\u2014Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European Society of, European Society of Cardiology: Cardiovascular Disease Statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1177\/107424840400900102","article-title":"Angina pectoris: The evolution of concepts","volume":"9","author":"Opie","year":"2004","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/01.CIR.0000139858.69915.2E","article-title":"Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: A three-vessel intravascular ultrasound study in 235 patients","volume":"110","author":"Hong","year":"2004","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199206203-00002","article-title":"Molecular mechanism of action of nicorandil","volume":"20","author":"Kukovetz","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"IONA Study Group (2002). Effect of nicorandil on coronary events in patients with stable angina: The Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet, 359, 1269\u20131275.","DOI":"10.1016\/S0140-6736(02)08265-X"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2010.11.032","article-title":"Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris","volume":"214","author":"Izumiya","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.biopha.2018.07.014","article-title":"Role of TLR4\/MyD88\/NF-kappaB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil","volume":"106","author":"Su","year":"2018","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2133.2004.06199.x","article-title":"A case of severe tongue ulceration and laryngeal inflammation induced by low-dose nicorandil therapy","volume":"151","author":"Jang","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1007\/s10620-011-1634-x","article-title":"Nicorandil associated colonic ulceration: Case series of an increasingly recognized complication","volume":"56","author":"Lee","year":"2011","journal-title":"Digest. Dis. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13256-016-0987-3","article-title":"Nicorandil-induced penile ulceration: A case report","volume":"10","author":"Yap","year":"2016","journal-title":"J. Med. Case Rep."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chen, C.C., Hong, H.J., Hao, W.R., Cheng, T.H., Liu, J.C., and Sung, L.C. (2019). Nicorandil prevents doxorubicin-induced human umbilical vein endothelial cell apoptosis. Eur. J. Pharmacol., 859.","DOI":"10.1016\/j.ejphar.2019.172542"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.fjc.0000184466.37951.76","article-title":"Nicorandil inhibits serum starvation-induced apoptosis in vascular endothelial cells","volume":"46","author":"Date","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.bbrc.2018.02.003","article-title":"The protective effect of nicorandil on cardiomyocyte apoptosis after coronary microembolization by activating Nrf2\/HO-1 signaling pathway in rats","volume":"496","author":"He","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3892\/ijmm.2013.1379","article-title":"Nicorandil inhibits hypoxia-induced apoptosis in human pulmonary artery endothelial cells through activation of mitoKATP and regulation of eNOS and the NF-kappaB pathway","volume":"32","author":"Wang","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0006-8993(03)03383-3","article-title":"Nicorandil prevents oxidative stress-induced apoptosis in neurons by activating mitochondrial ATP-sensitive potassium channels","volume":"990","author":"Teshima","year":"2003","journal-title":"Brain Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1016\/S0002-8703(99)70266-8","article-title":"Atherosclerosis is an inflammatory disease","volume":"138","author":"Ross","year":"1999","journal-title":"Am. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjp.0703407","article-title":"Apoptosis in the vasculature: Mechanisms and functional importance","volume":"130","author":"Mallat","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nm1459","article-title":"Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis","volume":"12","author":"Clarke","year":"2006","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/01.ATV.0000184783.04864.9f","article-title":"Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: The importance of lesion stage and phagocytic efficiency","volume":"25","author":"Tabas","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_22","first-page":"659","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Nihal","year":"2008","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Venegas-Pino, D.E., Banko, N., Khan, M.I., Shi, Y., and Werstuck, G.H. (2013). Quantitative analysis and characterization of atherosclerotic lesions in the murine aortic sinus. J. Vis. Exp.","DOI":"10.3791\/50933-v"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s10495-017-1388-9","article-title":"Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction","volume":"22","author":"Hohensinner","year":"2017","journal-title":"Apop. Int. J. Program. Cell Death"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1160\/TH14-06-0549","article-title":"Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro","volume":"113","author":"Krychtiuk","year":"2015","journal-title":"Thromb. Haemost."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Jacob, J.V. (2015). Nicorandil-induced colonic ulceration. BMJ Case Rep., 2015.","DOI":"10.1136\/bcr-2014-205310"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Samra, K., Manikam, L., and Pathmakanthan, S. (2015). When treatment can be worse than the disease: Nicorandil-induced colitis. BMJ Case Rep., 2015.","DOI":"10.1136\/bcr-2015-209799"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s10350-008-9218-3","article-title":"Nicorandil-induced colonic ulceration: A new cause of colonic ulceration","volume":"51","author":"Titi","year":"2008","journal-title":"Rep. Four Cases Dis. Colon Rectum"},{"key":"ref_29","first-page":"289","article-title":"Nicorandil ameliorates pulmonary inflammation and fibrosis in a rat model of silicosis","volume":"64","year":"2018","journal-title":"Int. Immun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1111\/jcmm.15169","article-title":"Intracoronary application of nicorandil regulates the inflammatory response induced by percutaneous coronary intervention","volume":"24","author":"Hu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/cns.12178","article-title":"Nicorandil inhibits inflammasome activation and Toll-like receptor-4 signal transduction to protect against oxygen-glucose deprivation-induced inflammation in BV-2 cells","volume":"20","author":"Zhao","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.yjmcc.2003.09.018","article-title":"Nicorandil inhibits oxidative stress-induced apoptosis in cardiac myocytes through activation of mitochondrial ATP-sensitive potassium channels and a nitrate-like effect","volume":"35","author":"Nagata","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.yjmcc.2006.01.020","article-title":"Nicorandil regulates Bcl-2 family proteins and protects cardiac myocytes against hypoxia-induced apoptosis","volume":"40","author":"Nishikawa","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_34","first-page":"725","article-title":"Protective effect of nicorandil on collapseinduced lung injury in rabbits by inhibiting apoptosis","volume":"44","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jns.2015.07.010","article-title":"Neuroprotective effect of nicorandil through inhibition of apoptosis by the PI3K\/Akt1 pathway in a mouse model of deep hypothermic low flow","volume":"357","author":"Yu","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e33367","DOI":"10.1371\/journal.pone.0033367","article-title":"Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension","volume":"7","author":"Sahara","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3892\/ijmm.2015.2229","article-title":"Nicorandil protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis","volume":"36","author":"Zhang","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jphs.2014.12.017","article-title":"Nicorandil prevents sirolimus-induced production of reactive oxygen species, endothelial dysfunction, and thrombus formation","volume":"127","author":"Aizawa","year":"2015","journal-title":"J. Pharmacol. Sci."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/2\/120\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:15:54Z","timestamp":1760159754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/2\/120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["biomedicines9020120"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9020120","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,27]]}}}